SCHEMBL4754231

SCHEMBL4754231

Cc1ccc([N+](=O)[O-])c(C(=O)N2CCN(Cc3c(C)nn(-c4ccccc4)c3C)CC2)c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BLM P54132 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
SMO Q99835 2/20 0.46
CYP46A1 Q9Y6A2 1/20 0.44
KDM4E B2RXH2 3/20 0.44
HTT P42858 2/20 0.43
LMNA P02545 1/20 0.43
ALDH1A1 P00352 4/20 0.43
MAPT P10636 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPK1 P28482 1/20 0.42
P2RX7 Q99572 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 2/20 0.41
OPRM1 P35372 1/20 0.41
MEN1 O00255 1/20 0.41
MGLL Q99685 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4751033 0.76 SMO (0.59) SMOKDM4EHTTLMNAALDH1A1
SCHEMBL4753305 0.70 NPC1 (0.53) SMOHTTALDH1A1MAPTMAPK1
SCHEMBL5338313 0.69 SMO (0.59) SMOKDM4ESMN1; SMN2MAPK1P2RX7
SCHEMBL13020231 0.67 OPRM1 (0.47) SMOMAPK1P2RX7NPC1RAB9A
SCHEMBL1195590 0.65 NPC1 (0.73) P2RX7NPC1RAB9AKMT2AMEN1
SCHEMBL8511047 0.65 PDE4B (0.62) L3MBTL1HTTALDH1A1MAPTSMN1; SMN2
SCHEMBL1194352 0.64 P2RX7 (0.70) P2RX7
SCHEMBL11722513 0.64 CA12 (0.70) HTTLMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL28709587 0.64 SIGMAR1 (0.56) BLML3MBTL1HTTLMNAALDH1A1
SCHEMBL466792 0.63 ALDH1A1 (0.54) KDM4EHTTLMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO claimed
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO disclosed